Home > Insights > boult.bites Biotech – Spring 2015

Authors: Joanna Peak , Jennifer O’Farrell , James Legg and David Wortley
26 April, 2015

Spotlight on second medical use claims

Claims directed to new therapeutic uses of known compounds, so-called second medical use claims, have been accepted by the European Patent Office for over 30 years. It has been widely recognised that the granting of second medical use patents incentivises important medical research. However, a great deal of uncertainty surrounds the enforcement of such patents, which creates problems for pharmaceutical companies and generics manufacturers alike.

Authors

joanna peak

Joanna Peak
Partner

Phone this number +44 (0)20 7430 7500

Email this address jpeak@boult.com

Verulam Gardens
70 Gray's Inn Road
London
WC1X 8BT

Jennifer O'Farrell

Jennifer O’Farrell
Partner

Phone this number +44 (0)20 7430 7500

Email this address jo'farrell@boult.com

Verulam Gardens
70 Gray's Inn Road
London
WC1X 8BT

james legg

James Legg
Partner

Phone this number +44 (0)1223 883000

Email this address jlegg@boult.com

CPC4 Capital Park
Cambridge Road
Cambridge
CB21 5XE

David Wortley

David Wortley
Patent Attorney

Phone this number +44 (0)1223 883000

Email this address dwortley@boult.com

CPC4 Capital Park
Cambridge Road
Cambridge
CB21 5XE